Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury

Experimental Neurology

Volumn 151, Issue 2, 1998, Pages 314-325

  Fagan, Anne M ^a   Murphy, Brian A ^a   Patel, Shilen N ^a   Kilbridge, Joshua F ^b   Mobley, William C ^b   Bu, Guojun ^a   Holtzman, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Apolipoprotein E; Basal forebrain cholinergic neurons; Cholesterol; Degeneration; Entorhinal cortex; Fimbria fornix; Hippocampus

Indexed keywords

APOLIPOPROTEIN E4; CHOLINE ACETYLTRANSFERASE;

AGING; ALLELE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CHOLINERGIC NERVE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; ENTORHINAL CORTEX; ENZYME ACTIVITY; FOREBRAIN; GENE DOSAGE; GENOTYPE; HIPPOCAMPUS; MOUSE; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032101868     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6818     Document Type: Article

References (74)

1. Alberts M. J., Graffagnino C., McClenny C., DeLong D., Strittmatter W., Saunders A. M., Roses A. D. ApoE genotype and survival from intracerebral hemorrhage. Lancet. 346:1995;575.
2. Bales K. R., Verina T., Dodel R. C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstone E. M., Little S. P., Cummins D. J., Piccardo P., Ghetti B., Paul S. M. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Gen. 17:1997;263-264.
3. Bellosta S., Nathan B. P., Orth M., Dong L., Mahley R. W., Pitas R. E. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270:1995;27063-27071.
4. Biere A. L., Ostaszewski B., Stimson E. R., Hyman B. T., Maggio J. E., Selkoe D. J. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271:1996;32916-32922.
5. Boyles J. K., Pitas R. E., Wilson E., Mahley R. W., Taylor J. M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76:1985;1501-1513.
6. Cavalieri B. Geometria Degli Indivisibili. 1966;Unione Tipografico, Torino.
7. Chen Y., Lomnitski L., Michaelson D. M., Shohami E. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience. 80:1997;1255-1262.
8. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
9. Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
10. Davies P., Maloney A. J. R. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403.
11. Ellison D. W., Beal M. F., Martin J. B. Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease. Brain Res. 417:1987;389-392.
12. Elshourbagy N. A., Liao W. S., Mahley R. W., Taylor J. M. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA. 82:1985;203-207.
13. Fagan A. M., Bu G., Sun Y., Daugherty A., Holtzman D. M. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein (LRP). J. Cell Biol. 271:1996;30121-30125.
14. Fagan A. M., Gage F. H. Mechanisms of sprouting in the adult CNS: cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus. Neuroscience. 58:1994;705-725.
15. Fagan A. M., Garber M., Barbacid M., Silos-Santiago I., Holtzman D. H. A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo. J. Neurosci. 17:1997;7644-7654.
16. Fagan A. M., Suhr S. T., Lucidi-Phillipi C. A., Peterson D. A., Holtzman D. M., Gage F. H. Endogenous FGF-2 is important for cholinergic sprouting in the denervated hippocampus. J. Neurosci. 17:1997;2499-2511.
17. Fonnum F. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115:1969;465-472.
18. Gage F. H., Wictorin K., Fisher W., Williams L. R., Varon S., Bjorklund A. Life and death of cholinergic neurons in the septal and diagonal band region following complete fimbria-fornix transection. Neuroscience. 19:1986;241-255.
19. Gandy S. E., Stafstrom C., Turner B., Sweeney D., Breslow J., Greengard P., Smith J., Ouimet C. Aged apoE deficient mice: Abnormal learning and glial markers but no obvious neuropathology. Soc. Neurosci. Abstracts. 21:1995;5.
20. Geldmacher D. S., Whitehouse P. J. Evaluation of dementia. New Eng. J. Med. 335:1996;330-336.
21. Gokhale A. M. Unbiased estimation of curve length in 3-D using vertical slices. J. Microsc. 159:1990;133-141.
22. Goodrum J. F. Cholesterol from degenerating nerve myelin becomes associated with lipoproteins containing apolipoprotein E. J. Neurochem. 56:1991;2082-2086.
23. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D. M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
24. Guela, C. M. M. Mesulam, 1994, Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease, Alzheimer Disease, 263, 291, Raven Press, New York.
25. Gundersen H. J. G. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J. Microsc. 143:1986;3-45.
26. Hefti F., Dravid A., Hartikka J. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septohippocampal lesions. Brain Res. 293:1984;305-311.
27. Hefti F., Hartikka J., Salvatierra A., Weiner W. J., Mash D. C. Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain. Neurosci. Lett. 69:1986;37-41.
28. Holtzman D., Santucci D., Kilbridge J., Chua-Couzens J., Fontana D., Daniels S., Johnson R., Chen K., Sun Y., Carlson E., Alleva E., Epstein C., Mobley W. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc. Natl. Acad. Sci. USA. 93:1996;13333-13338.
29. Holtzman D. M., Kilbridge J., Bredt D. S., Black S. M., Li Y., Clary D. O., Reichardt L. F., Mobley W. C. NOS induction by NGF in basal forebrain cholinergic neurons: evidence for regulation of brain NOS by a neurotrophin. Neurobiol. Disease. 1:1994;51-60.
30. Holtzman D. M., Pitas R. E., Kilbridge J., Nathan B., Mahley R. W., Bu G., Schwartz A. L. LRP mediates apolipoprotein E-dependent neurite outgrowth in a CNS-derived neuronal cell line. Proc. Natl. Acad. Sci. USA. 92:1995;9480-9484.
31. Koudinov A. R., Koudinova N. V., Kumar A., Beavis R. C., Ghiso J. Biochemical characterization of Alzheimer's soluble beta protein in human cerebrospinal fluid - association with high density lipoprotein. Biochem. Biophys. Res. Commun. 223:1996;592-597.
32. Kowall N. W., Kosik K. S. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease. Ann. Neurol. 22:1987;639-643.
33. LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. S., Falduto M. T. Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J. Biol. Chem. 270:1995;9030-9042.
34. Li Y., Holtzman D. M., Kromer L. F., Kaplan D. R., Chua-Couzens J., Clary D. O., Knusel B., Mobley W. C. Regulation of trkA and ChAT expression in developing rat basal forebrain: Evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J. Neurosci. 15:1995;2888-2905.
35. Lynch, G. G. Rose, C. Gall, C. W. Cotman, 1975, The response of the dentate gyrus to partial deafferentation, Golgi Centennial Symposium. Proceedings, 305, 317, Raven Press, New York.
36. Mahley R. W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
37. Masliah E., Mallory M., Alford M., Ge N., Mucke L. Abnormal synaptic regeneration in hAPP695 transgenic and apoE knockout mice. Iqbal K., Mortimer J. A., Winblad B., Wisniewski H. M. Research Advances in Alzheimer's Disease and Related Disorders. 1995;405-414 Wiley, New York.
38. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A. D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
39. Matthews D., Cotman C., Lynch G. An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. I. Magnitude and timecourse of degeneration. Brain Res. 115:1976;1-21.
40. Mayeux R., Stern Y., Ottman R., Tatemichi T. K., Tang M.-X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann. Neurol. 34:1993;752-754.
41. Nakai M., Kawamata T., Taniguchi T., Maeda K., Tanaka C. Expression of apolipoprotein E mRNA in rat microglia. Neurosci. Lett. 211:1996;41-44.
42. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res. 541:1991;163-166.
43. Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., Pitas R. E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
44. Nicoll J. A. R., Roberts G. W., Graham D. I. ApoE E4 allele is associated with deposition of amyloid beta-protein following head injury. Nature Med. 1:1995;135-137.
45. Nitsch R. M., Blusztajn J. K., Pittas A. G., Slack B. E., Growdon J. H., Wurtman R. J. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA. 89:1992;1671-1675.
46. Peterson D. A., Leppert J. T., Lee K. F., Gage F. H. Basal forebrain neuronal loss in mice lacking neurotrophin receptor p75. Science. 277:1997;837-839.
47. Piedrahita J. A., Zhang S. H., Hagaman J. R., Oliver P. M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:1992;4471-4475.
48. Pitas R. E., Boyles J. K., Lee S. H., Foss D., Mahley R. W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta. 917:1987;148-161.
49. Pitas R. E., Boyles J. K., Lee S. H., Hui D., Weisgraber K. H. Lipoproteins and their receptors in the central nervous system. J. Biol. Chem. 262:1987;14352-14360.
50. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
51. Poirer J. Apolipoprotein E in animal models of CNS injury and Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
52. Poirier J., Hess M., May P. C., Finch C. E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11:1991;97-106.
53. Rebeck G. W., Reiter J. S., Strickland D. K., Hyman B. T. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron. 11:1993;575-580.
54. Roheim P. S., Carey M., Forte T., Vega G. L. Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA. 76:1979;4646-4649.
55. Schauwecker P. E., Steward O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc. Natl. Acad. Sci. USA. 94:1997;4103-4108.
56. Selkoe D. J. Alzheimer's disease: A central role for amyloid. J. Neuropath. Exp. Neurol. 53:1994;438-447.
57. Selkoe D. J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science. 275:1997;630-631.
58. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljarvi L., Talasniemi S., Ryynanen M., Riekkinen P. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ε4 allele. Neurosci. Lett. 187:1995;79-82.
59. Stone D. J., Rozovsky I., Morgan T. E., Anderson C. P., Hajian H., Finch C. E. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 143:1997;313-318.
60. Strittmatter W. J., Saunders A. M., Goedert M., Weisgraber K. H., Dong L.-M., Jakes R., Huang D. Y., Pericak-Vance M., Schmechel D., Roses A. D. Isoform-specific interactions of apolipoprotein E with microtubule-associated tau: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;11183-11186.
61. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
62. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L.-Y., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Roses A. D. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform specific-effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8098-8102.
63. Suzuki K., Suzuki K., Kamoshita S. Chemical pathology of GM1 gangliosidosis. J. Neuropath. Exp. Neurol. 28:1969;25-73.
64. Teasdale M. G., Nicoll J. A. R., Murray G., Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet. 350:1997;1069-1071.
65. Tuszynski M. H., Armstrong D. M., Gage F. H. Basal forebrain cell loss following fimbria/fornix transection. Brain Res. 508:1990;241-248.
66. NGFR. Science. 274:1996;1729-1732.
67. Weskamp G., Reichardt L. F. Evidence that biological activity of NGF is mediated through a novel subclass of high-affinity receptors. Neuron. 6:1991;649-663.
68. West M. J. New stereological methods for counting neurons. Neurobiol. Aging. 14:1993;275-285.
69. Wisniewski T., Frangione B. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
70. Xin L., Richardson P. M., Gervais F., Skamene E. A deficiency of axonal regeneration in C57Bl/6J mice. Brain Res. 510:1990;144-146.
71. Yang D. S., Smith J. D., Zhou Z. M., Gandy S. E., Martins R. N. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J. Neurochem. 68:1997;721-725.
72. NTR. J. Neurosci. 17:1997;7594-7605.
73. Zareparsi S., Kaye J., Camicioli R., Grimslid H., Oken B., Litt M., Nutt J., Bird T., Schellenberg G., Payami H. Modulation of age at onset of Parkinson's disease by apolipoprotein E genotypes. Ann. Neurol. 42:1997;655-658.
74. Zhang S. H., Reddick R. L., Piedrahita J. A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.